Can an Old Ally Defeat a New Enemy?

por Gurbel, Paul A., Bliden, Kevin P., Schrör, Karsten
Publicado 2020

Further evidence for the use of aspirin in COVID-19

por Tantry, Udaya S., Bliden, Kevin P., Gurbel, Paul A.
Publicado 2022

Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent

por Tantry, Udaya S, Schror, Karsten, Navarese, Eliano Pio, Jeong, Young-Hoon, Kubica, Jacek, Bliden, Kevin P, Gurbel, Paul A
Publicado 2021

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations

por Chaudhary, Rahul, Bliden, Kevin P., Kreutz, Rolf P., Jeong, Young-Hoon, Tantry, Udaya S., Levy, Jerrold H., Gurbel, Paul A.
Publicado 2020

Influence of Race and Sex on Thrombogenicity in a Large Cohort of Coronary Artery Disease Patients

por Lev, Eli I., Bliden, Kevin P., Jeong, Young‐Hoon, Pandya, Shachi, Kang, Kelly, Franzese, Christopher, Tantry, Udaya S., Gurbel, Paul A.
Publicado 2014

Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study

por Gurbel, Paul A., Tantry, Udaya S., D’Andrea, Denise, Chung, Thomas, Alexander, John H., Bliden, Kevin P., Wright, Samuel D., Tricoci, Pierluigi
Publicado 2018

Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority pop...

por Gurbel, Paul A., Bliden, Kevin P., Rout, Amit, Rapista, Nicole, Walia, Naval, Chaudhary, Rahul, Ens, Gordon, Traianova, Malina, Barnes, Jaime S., Tantry, Udaya S.
Publicado 2021

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes

por Usman, Abira, Bliden, Kevin P., Cho, Alastair, Walia, Naval, Jerjian, Christophe, Singh, Arvind, Kundan, Parshotam, Duhan, Sanchit, Tantry, Udaya S., Gurbel, Paul A.
Publicado 2022

First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19

por Tantry, Udaya S, Bliden, Kevin P, Cho, Alastair, Walia, Naval, Dahlen, Jeffrey R, Ens, Gordon, Traianova, Malina, Jerjian, Christophe, Usman, Abira, Gurbel, Paul A
Publicado 2021

PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterizati...

por Kuliopulos, Athan, Gurbel, Paul A., Rade, Jeffrey J., Kimmelstiel, Carey D., Turner, Susan E., Bliden, Kevin P., Fletcher, Elizabeth K., Cox, Daniel H., Covic, Lidija
Publicado 2020

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention

por Jeong, Young-Hoon, Tantry, Udaya S., Park, Yongwhi, Kwon, Tae Jung, Park, Jeong Rang, Hwang, Seok-Jae, Bliden, Kevin P., Koh, Eun-Ha, Kwak, Choong Hwan, Hwang, Jin-Yong, Kim, Sunjoo, Gurbel, Paul A.
Publicado 2012

Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases

por Katagiri, Daisuke, Asai, Yusuke, Ohmagari, Norio, Ishikane, Masahiro, Hikida, Sayaka, Iwamoto, Noriko, Nagashima, Maki, Suzuki, Minami, Takano, Hideki, Takasaki, Jin, Hojo, Masayuki, Sugiyama, Haruhito, Tokunaga, Katsushi, Miyashita, Yoshihiro, Omata, Masao, Ohata, Keiichi, Bliden, Kevin P., Tantry, Udaya S., Dahlen, Jeffrey R., Sugaya, Takeshi, Gurbel, Paul A., Noiri, Eisei
Publicado 2023